Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Licitra

Showing results (1-10 of 311) with videos related to

Pageof 32
Sort By:
Frontiers in Oncology|December 5, 2019
Editorial: Advances in the Systemic Therapy and Combined Modality Approaches for Head and Neck CancerAthanassios Argiris, Lisa Licitra
JAMA Otolaryngology-- Head & Neck Surgery|November 24, 2017
Personalized Medicine and the Contradictions and Limits of First-Generation Deescalation Trials in Patients With Human Papillomavirus-Positive Oropharyngeal CancerEster Orlandi, Lisa Licitra
Nature Reviews. Clinical Oncology|April 30, 2010
Chemotherapy: Chemoradiation in head-and-neck cancer-are we any closer?Jacques Bernier, Lisa Licitra
The Lancet. Oncology|April 15, 2021
Next generation platinum salt in nasopharygeal carcinomaStefano Cavalieri, Lisa Licitra
Thyroid : Official Journal of the American Thyroid Association|September 3, 2014
Antiangiogenic TKIs and advanced RAI-resistant thyroid cancer: time for rethinking treatment strategies?Lisa Licitra, Laura Locati
Cancer|June 5, 2020
Induction chemotherapy is the best timekeeper in nasopharyngeal carcinomaStefano Cavalieri, Lisa Licitra
International Journal of Radiation Oncology, Biology, Physics|August 2, 2016
How Much of the Future Can Be Read Through the Skin?Giuseppe Sanguineti, Lisa Licitra
Future Oncology (London, England)|June 27, 2019
The day after De-ESCALaTE and RTOG 1016 trials resultsEster Orlandi, Lisa Licitra
Lancet (London, England)|November 5, 2019
PD-1 immunotherapy for recurrent or metastatic HNSCCRobert L Ferris, Lisa Licitra
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2006
Systemic therapy in the palliative management of advanced salivary gland cancersScott A Laurie, Lisa Licitra
Pageof 32

Showing results (1-10 of 311) with videos related to

Sort By:
Pageof 32
Frontiers in Oncology|December 5, 2019
Editorial: Advances in the Systemic Therapy and Combined Modality Approaches for Head and Neck CancerAthanassios Argiris, Lisa Licitra
JAMA Otolaryngology-- Head & Neck Surgery|November 24, 2017
Personalized Medicine and the Contradictions and Limits of First-Generation Deescalation Trials in Patients With Human Papillomavirus-Positive Oropharyngeal CancerEster Orlandi, Lisa Licitra
Nature Reviews. Clinical Oncology|April 30, 2010
Chemotherapy: Chemoradiation in head-and-neck cancer-are we any closer?Jacques Bernier, Lisa Licitra
The Lancet. Oncology|April 15, 2021
Next generation platinum salt in nasopharygeal carcinomaStefano Cavalieri, Lisa Licitra
Thyroid : Official Journal of the American Thyroid Association|September 3, 2014
Antiangiogenic TKIs and advanced RAI-resistant thyroid cancer: time for rethinking treatment strategies?Lisa Licitra, Laura Locati
Cancer|June 5, 2020
Induction chemotherapy is the best timekeeper in nasopharyngeal carcinomaStefano Cavalieri, Lisa Licitra
International Journal of Radiation Oncology, Biology, Physics|August 2, 2016
How Much of the Future Can Be Read Through the Skin?Giuseppe Sanguineti, Lisa Licitra
Future Oncology (London, England)|June 27, 2019
The day after De-ESCALaTE and RTOG 1016 trials resultsEster Orlandi, Lisa Licitra
Lancet (London, England)|November 5, 2019
PD-1 immunotherapy for recurrent or metastatic HNSCCRobert L Ferris, Lisa Licitra
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2006
Systemic therapy in the palliative management of advanced salivary gland cancersScott A Laurie, Lisa Licitra
Pageof 32